Gefitinib

CAS 184475-35-2

Overview

Gefitinib, sold under the brand name Iressa, is a medication used for certain breast, lung and other cancers. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor in target cells

Anant Labs manufacture and furnish high quality Gefitinib impurities for global markets. Our Gefitinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

In Stock

Gefitinib

Cat. No. ANTPRD5545Old No. ANT-GFT-00CAS 184475-35-2In Stock

Technical Data

New Cat. No.ANTPRD5545

Old Cat. No.ANT-GFT-00

CAS184475-35-2

Mol. FormulaC₂₂H₂₄ClFN₄O₃

Mol. Weight446.91 g/mol

IUPACN-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine

SMILESCOC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4

InChIInChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21(20)31-8-2-5-28-6-9-30-10-7-28)22(26-14-25-19)27-15-3-4-18(24)17(23)11-15/h3-4,11-14H,2,5-10H2,1H3,(H,25,26,27)

InChI KeyXGALLCVXEZPNRQ-UHFFFAOYSA-N

Synonyms

N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amineGefitinib184475-35-2IressaZD1839IrressatZD-1839ZD 1839N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamineN-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine